|
OMIM |
Link |
Information gain |
01 |
|
EC1
|
[NCBI]
|
0.00573783
|
|
|
GPS
|
[NCBI]
|
0.00122186
|
|
|
SLE
|
[NCBI]
|
0.000818053
|
|
|
FCAR
|
[NCBI]
|
0.000360665
|
|
|
FCGR3A
|
[NCBI]
|
0.000334726
|
|
|
PIGR
|
[NCBI]
|
0.000303015
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00027217
|
|
|
RA
|
[NCBI]
|
0.000253206
|
|
|
FCGR2A
|
[NCBI]
|
0.000236639
|
|
|
FCGRT
|
[NCBI]
|
0.00012685
|
|
|
FCER1A
|
[NCBI]
|
0.000123922
|
|
|
TNF
|
[NCBI]
|
0.000105254
|
|
|
CF
|
[NCBI]
|
0.000100325
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
9.95086e-05
|
|
|
FCGR1A
|
[NCBI]
|
9.76434e-05
|
|
|
FCER2
|
[NCBI]
|
9.1579e-05
|
|
|
IL4
|
[NCBI]
|
9.14128e-05
|
|
|
fc fragment of iga and igm, receptor for
|
[NCBI]
|
7.99019e-05
|
|
|
LILRA3
|
[NCBI]
|
6.5061e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
6.47907e-05
|
|
|
FCER1G
|
[NCBI]
|
5.74913e-05
|
|
|
MS4A2
|
[NCBI]
|
5.09798e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.86478e-05
|
|
|
CMT1B
|
[NCBI]
|
4.57846e-05
|
|
|
LILRB5
|
[NCBI]
|
3.99337e-05
|
|
|
fc receptor-like protein 1
|
[NCBI]
|
3.99337e-05
|
|
|
LILRA1
|
[NCBI]
|
3.99337e-05
|
|
|
osteoclast-associated receptor
|
[NCBI]
|
3.99337e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 1
|
[NCBI]
|
3.99337e-05
|
|
|
LAD
|
[NCBI]
|
3.55451e-05
|
|
|
CHH
|
[NCBI]
|
3.29201e-05
|
|
|
LENG4
|
[NCBI]
|
3.25132e-05
|
|
|
SPAP1
|
[NCBI]
|
3.25132e-05
|
|
|
KIR2DS5
|
[NCBI]
|
3.25132e-05
|
|
|
KIR2DS1
|
[NCBI]
|
3.25132e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 2
|
[NCBI]
|
3.25132e-05
|
|
|
LENG5
|
[NCBI]
|
3.25132e-05
|
|
|
fc receptor homolog expressed in b cells
|
[NCBI]
|
3.25132e-05
|
|
|
B2M
|
[NCBI]
|
3.00585e-05
|
|
|
MAL2
|
[NCBI]
|
2.97144e-05
|
|
|
CD300C
|
[NCBI]
|
2.97144e-05
|
|
|
KIR2DS4
|
[NCBI]
|
2.97144e-05
|
|
|
immunoglobulin-like transcript 11
|
[NCBI]
|
2.97144e-05
|
|
|
FCRL3
|
[NCBI]
|
2.97144e-05
|
|
|
MR1
|
[NCBI]
|
2.97144e-05
|
|
|
BCGF
|
[NCBI]
|
2.85767e-05
|
|
|
IGBP1
|
[NCBI]
|
2.78979e-05
|
|
|
LILRB3
|
[NCBI]
|
2.78979e-05
|
|
|
IGHA1
|
[NCBI]
|
2.78979e-05
|
|
|
LILRB4
|
[NCBI]
|
2.65479e-05
|
|
|
LILRB2
|
[NCBI]
|
2.65479e-05
|
|
|
LILRA2
|
[NCBI]
|
2.65479e-05
|
|
|
KIR3DL2
|
[NCBI]
|
2.65479e-05
|
|
|
KIR2DL3
|
[NCBI]
|
2.54727e-05
|
|
|
RPS9
|
[NCBI]
|
2.54727e-05
|
|
|
KIR2DL4
|
[NCBI]
|
2.45791e-05
|
|
|
WBSCR5
|
[NCBI]
|
2.38146e-05
|
|
|
RAP1B
|
[NCBI]
|
2.31466e-05
|
|
|
TPD52
|
[NCBI]
|
2.25534e-05
|
|
|
TNFSF4
|
[NCBI]
|
2.15357e-05
|
|
|
KIR3DL1
|
[NCBI]
|
2.1092e-05
|
|
|
MERTK
|
[NCBI]
|
2.1092e-05
|
|
|
FCGR2B
|
[NCBI]
|
2.1092e-05
|
|
|
KIR2DL1
|
[NCBI]
|
2.06828e-05
|
|
|
IL2
|
[NCBI]
|
2.00234e-05
|
|
|
EGF
|
[NCBI]
|
1.99809e-05
|
|
|
ITGA2
|
[NCBI]
|
1.99489e-05
|
|
|
ITGB1
|
[NCBI]
|
1.79743e-05
|
|
|
PTPRC
|
[NCBI]
|
1.47544e-05
|
|
|
USF1
|
[NCBI]
|
1.42739e-05
|
|
|
RNASE3
|
[NCBI]
|
1.39919e-05
|
|
|
IL2RA
|
[NCBI]
|
1.3835e-05
|
|
|
IGHG1
|
[NCBI]
|
1.34312e-05
|
|
|
MG
|
[NCBI]
|
1.33479e-05
|
|
|
ITGB2
|
[NCBI]
|
1.32409e-05
|
|
|
IL3
|
[NCBI]
|
1.12635e-05
|
|
|
LAT
|
[NCBI]
|
1.05649e-05
|
|
|
HRG
|
[NCBI]
|
1.0511e-05
|
|
|
TLR4
|
[NCBI]
|
9.79498e-06
|
|
|
NSF
|
[NCBI]
|
9.76836e-06
|
|
|
TNFSF11
|
[NCBI]
|
9.2485e-06
|
|
|
RNASE2
|
[NCBI]
|
8.78113e-06
|
|
|
LPO
|
[NCBI]
|
8.19169e-06
|
|
|
IL6
|
[NCBI]
|
7.17994e-06
|
|
|
MCP
|
[NCBI]
|
7.10328e-06
|
|
|
PTH
|
[NCBI]
|
6.45147e-06
|
|
|
COMP
|
[NCBI]
|
5.71727e-06
|
|
|
NPY
|
[NCBI]
|
4.54535e-06
|
|
|
MBL2
|
[NCBI]
|
4.25725e-06
|
|
|
LRP1
|
[NCBI]
|
4.25725e-06
|
|
|
CVID
|
[NCBI]
|
4.25586e-06
|
|
|
RASA1
|
[NCBI]
|
4.19725e-06
|
|
|
NGFB
|
[NCBI]
|
2.47967e-06
|
|
|
MPO
|
[NCBI]
|
2.02371e-06
|
|
|
SOD2
|
[NCBI]
|
2.01811e-06
|
|
|
GFAP
|
[NCBI]
|
1.79807e-06
|
|
|
VIP
|
[NCBI]
|
1.66599e-06
|
|
|
BDNF
|
[NCBI]
|
1.15974e-06
|
|
|
CNTF
|
[NCBI]
|
1.14449e-06
|
|
|
TF
|
[NCBI]
|
8.34242e-07
|
|
|
MBP
|
[NCBI]
|
4.68172e-07
|
|
|
LPL
|
[NCBI]
|
2.69069e-07
|
|
|
ADA
|
[NCBI]
|
1.7538e-07
|
|
|
G6PD
|
[NCBI]
|
1.70658e-07
|
|
|
TG
|
[NCBI]
|
1.11565e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
8.70841e-08
|
|
|
TNFSF6
|
[NCBI]
|
8.63578e-08
|
|
|
EPO
|
[NCBI]
|
3.78237e-09
|
|